Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 78
Filter
Add more filters

Publication year range
1.
Eur Radiol ; 33(1): 391-400, 2023 Jan.
Article in English | MEDLINE | ID: mdl-35852573

ABSTRACT

OBJECTIVES: Multidrug-resistant tuberculosis (MDR-TB) is a major challenge to global health security. Early identification of MDR-TB patients increases the likelihood of treatment success and interrupts transmission. We aimed to develop a predictive model for MDR to cavitary pulmonary TB using CT radiomics features. METHODS: This retrospective study included 257 consecutive patients with proven active cavitary TB (training cohort: 187 patients from Beijing Chest Hospital; testing cohort: 70 patients from Infectious Disease Hospital of Heilongjiang Province). Radiomics features were extracted from the segmented cavitation. A radiomics model was constructed to predict MDR using a random forest classifier. Meaningful clinical characteristics and subjective CT findings comprised the clinical model. The radiomics and clinical models were combined to create a combined model. ROC curves were used to validate the capability of the models in the training and testing cohorts. RESULTS: Twenty-one radiomics features were selected as optimal predictors to build the model for predicting MDR-TB. The AUCs of the radiomics model were significantly higher than those of the clinical model in either the training cohort (0.844 versus 0.589, p < 0.05) or the testing cohort (0.829 versus 0.500, p < 0.05). The AUCs of the radiomics model were slightly lower than those of the combined model in the training cohort (0.844 versus 0.881, p > 0.05) and testing cohort (0.829 versus 0.834, p > 0.05), but there was no significant difference. CONCLUSIONS: The radiomics model has the potential to predict MDR in cavitary TB patients and thus has the potential to be a diagnostic tool. KEY POINTS: • This is the first study to build and validate models that distinguish MDR-TB from DS-TB with clinical and radiomics features based on cavitation. • The radiomics model demonstrated good performance and might potentially aid in prior TB characterisation treatment. • This noninvasive and convenient technique can be used as a diagnosis tool into routine clinical practice.


Subject(s)
Tuberculosis, Multidrug-Resistant , Tuberculosis, Pulmonary , Humans , Retrospective Studies , Tuberculosis, Pulmonary/diagnostic imaging , Tuberculosis, Multidrug-Resistant/diagnostic imaging , Machine Learning , Drug Resistance, Multiple
2.
Eur Radiol ; 33(9): 6308-6317, 2023 Sep.
Article in English | MEDLINE | ID: mdl-37004571

ABSTRACT

OBJECTIVES: Multidrug-resistant TB (MDR-TB) is a severe burden and public health threat worldwide. This study aimed to develop a radiomics model based on the tree-in-bud (TIB) sign and nodules and validate its predictive performance for MDR-TB. METHODS: We retrospectively recruited 454 patients with proven active TB from two hospitals and classified them into three training and testing cohorts: TIB (n = 295, 102), nodules (n = 302, 97), and their combination (n = 261, 81). Radiomics features relating to TIB and nodules were separately extracted. The maximal information coefficient and recursive feature elimination were used to select informative features per the two signs. Two radiomics models were constructed to predict MDR-TB using a random forest classifier. Then, a combined model was built incorporating radiomics features based on these two signs. The capability of the models in the combined training and testing cohorts was validated with ROC curves. RESULTS: Sixteen features were extracted from TIB and 15 from nodules. The AUCs of the combined model were slightly higher than those of the TIB model in the combined training cohort (0.911 versus 0.877, p > 0.05) and testing cohort (0.820 versus 0.786, p < 0.05) and similar to the performance of the nodules model in the combined training cohort (0.911 versus 0.933, p > 0.05) and testing cohort (0.820 versus 0.855, p > 0.05). CONCLUSIONS: The CT-based radiomics models hold promise for use as a non-invasive tool in the prediction of MDR-TB. CLINICAL RELEVANCE STATEMENT: Our study revealed that complementary information regarding MDR-TB can be provided by radiomics based on the TIB sign and nodules. The proposed radiomics models may be new markers to predict MDR in active TB patients. KEY POINTS: • This is the first study to build, validate, and apply radiomics based on tree-in-bud sign and nodules for the prediction of MDR-TB. • The radiomics model showed a favorable performance for the identification of MDR-TB. • The combined model holds potential to be used as a diagnostic tool in routine clinical practice.


Subject(s)
Tomography, X-Ray Computed , Tuberculosis, Multidrug-Resistant , Humans , Retrospective Studies , Tuberculosis, Multidrug-Resistant/diagnostic imaging , Lung , Drug Resistance, Multiple
3.
Anal Chem ; 92(7): 5311-5318, 2020 04 07.
Article in English | MEDLINE | ID: mdl-32142258

ABSTRACT

Automated genotyping of drug-resistant Mycobacterium tuberculosis (MTB) directly from sputum is challenging for three primary reasons. First, the sample matrix, sputum, is highly viscous and heterogeneous, posing a challenge for sample processing. Second, acid-fast MTB bacilli are difficult to lyse. And third, there are hundreds of MTB mutations that confer drug resistance. An additional constraint is that MTB is most prevalent where test affordability is paramount. We address the challenge of sample homogenization and cell lysis using magnetic rotation of an external magnet, at high (5000) rpm, to induce the rotation of a disposable stir disc that causes chaotic mixing of glass beads ("MagVor"). Nucleic acid is purified using a pipet tip with an embedded matrix that isolates nucleic acid ("TruTip"). We address the challenge of cost and genotyping multiple mutations using 203 porous three-dimensional gel elements printed on a film substrate and enclosed in a microfluidic laminate assembly ("Lab-on-a-Film"). This Lab-on-a-Film assembly (LFA) serves as a platform for amplification, hybridization, washing, and fluorescent imaging, while maintaining a closed format to prevent amplicon contamination of the workspace. We integrated and automated MagVor homogenization, TruTip purification, and LFA amplification in a multisample, sputum-to-genotype system. Using this system, we report detection down to 43 cfu/mL of MTB bacilli from raw sputum.


Subject(s)
Automation , Lab-On-A-Chip Devices , Mycobacterium tuberculosis/genetics , Optical Imaging , Sputum/microbiology , Tuberculosis, Multidrug-Resistant/diagnostic imaging , Genotype , Humans , Optical Imaging/instrumentation
4.
Mol Pharm ; 15(10): 4326-4335, 2018 10 01.
Article in English | MEDLINE | ID: mdl-29257894

ABSTRACT

While tuberculosis (TB) disease was discovered more than a century ago, it has not been eradicated yet. Quite contrary, at present, TB constitutes one of the top 10 causes of death and has shown signs of increasing. To complement the conventional diagnostic procedure of applying microbiological culture that takes several weeks and remains expensive, high resolution computer tomography (CT) of pulmonary images has been resorted to not only for aiding clinicians to expedite the process of diagnosis but also for monitoring prognosis when administering antibiotic drugs. This research undertakes the investigation of predicting multidrug-resistant (MDR) patients from drug-sensitive (DS) ones based on CT lung images to monitor the effectiveness of treatment. To contend with smaller data sets (i.e., hundreds) and the characteristics of CT TB images with limited regions capturing abnormities, patch-based deep convolutional neural network (CNN) allied to support vector machine (SVM) classifier is implemented on a collection of data sets from 230 patients obtained from the ImageCLEF 2017 competition. As a result, the proposed architecture of CNN + SVM + patch performs the best with classification accuracy rate at 91.11% (79.80% in terms of patches). In addition, a hand-crafted SIFT based approach accomplishes 88.88% in terms of subject and 83.56% with reference to patches, the highest in this study, which can be explained away by the fact that the data sets are in small numbers. Significantly, during the Tuberculosis Competition at ImageCLEF 2017, the authors took part in the task of classification of 5 types of TB disease and achieved the top one with regard to averaged classification accuracy (i.e., ACC = 0.4067), which is also premised on the approach of CNN + SVM + patch. On the other hand, when the whole slices of 3D TB data sets are applied to train a CNN network, the best result is achieved through the application of CNN coupled with orderless pooling and SVM at 64.71% accuracy rate.


Subject(s)
Deep Learning , Tomography, X-Ray Computed/methods , Tuberculosis, Multidrug-Resistant/diagnostic imaging , Humans , Neural Networks, Computer , Support Vector Machine
7.
Int J Mycobacteriol ; 12(3): 282-288, 2023.
Article in English | MEDLINE | ID: mdl-37721233

ABSTRACT

Background: Making a preliminary diagnosis using X-ray methods for the study of resistant and resistant tuberculosis (TB) will help to make a preliminary diagnosis and determine further tactics for the treatment of TB, even with limited resources for microbiological diagnosis of drug resistance of TB. The present study was aimed at identifying chest X-ray differences between susceptible and resistant TB. Methods: A prospective cohort study of data from all consecutive patients with culture-confirmed pulmonary TB admitted during the year to the Kharkiv TB Dispensary No. 1 in Kharkiv, Ukraine. Results: One hundred and sixty-eight patients with lung TB were examined. Patients were divided into two groups: 1st patients with pulmonary TB with resistance of Mycobacterium tuberculosis (MTB) to at least isoniazid and rifampicin (resistant TB) and 2nd pulmonary TB with preserved susceptibility of MTB to anti-TB drugs (susceptible-TB). Patients of 1st group often had lesions in two lobes of the lungs 31.1% and one lung 43.3% versus 15.4% and 2.6% of patients with susceptible TB (P < 0.001). In addition, more than 3 cavities in the lungs 45.5% were significantly more often observed in patients with resistant TB versus 7.9%-the 2nd group (P < 0.001). Smaller cavities were observed in patients with susceptible TB up to 1.99 cm 74% versus 35.2% in 1st group (P < 0.001). We did not observe any significant radiological features depending on the right or left lung, as well as the lobar localization of the TB process. Conclusions: For resistant forms of TB, radiologically, a more widespread TB process in the lungs with the presence of a larger number of cavities and their larger size against a background of a more pronounced clinical picture and mycobacterium excretion than with susceptible TB is characteristic.


Subject(s)
Mycobacterium tuberculosis , Tuberculosis, Multidrug-Resistant , Tuberculosis, Pulmonary , Humans , Prospective Studies , X-Rays , Tuberculosis, Multidrug-Resistant/diagnostic imaging , Tuberculosis, Multidrug-Resistant/drug therapy , Antitubercular Agents/pharmacology , Antitubercular Agents/therapeutic use , Lung/diagnostic imaging , Tuberculosis, Pulmonary/diagnostic imaging , Tuberculosis, Pulmonary/drug therapy , Microbial Sensitivity Tests
8.
Neurol India ; 60(2): 231-4, 2012.
Article in English | MEDLINE | ID: mdl-22626710

ABSTRACT

Despite tuberculosis (TB) being endemic in many parts of the world, its prevalence in infancy is low. Neurotuberculosis in this age is even rarer and presents either as meningitis or intracranial tuberculoma on the background of exposure to the disease. We report occurrence of multidrug-resistant tuberculous subdural empyema in a three-month-old girl as the initial presenting manifestation of TB in the absence of any exposure to the disease. She was successfully managed with surgery and drugs with good outcome at 18 months.


Subject(s)
Empyema, Subdural/microbiology , Methicillin-Resistant Staphylococcus aureus , Staphylococcal Infections/complications , Tuberculoma, Intracranial/microbiology , Tuberculosis, Multidrug-Resistant/complications , Empyema, Subdural/diagnostic imaging , Empyema, Subdural/pathology , Female , Humans , Infant , Radiography , Staphylococcal Infections/diagnostic imaging , Staphylococcal Infections/pathology , Tuberculoma, Intracranial/diagnostic imaging , Tuberculoma, Intracranial/pathology , Tuberculosis, Multidrug-Resistant/diagnostic imaging , Tuberculosis, Multidrug-Resistant/pathology
9.
Comput Intell Neurosci ; 2022: 3141807, 2022.
Article in English | MEDLINE | ID: mdl-35634067

ABSTRACT

The drug resistance and influencing factors of patients with pulmonary tuberculosis were investigated, and a dual attention dilated residual network (DADRN) algorithm was proposed. The algorithm was applied to process and analyze lung computed tomography (CT) images of 400 included patients with pulmonary tuberculosis. Besides, sparse code book algorithm and bag of visual word (BOVW) algorithms were introduced and compared, and the influencing factors of pulmonary tuberculosis drug resistance were analyzed. The results demonstrated that the localization precision of lung consolidation, nodules, and cavities by the DADRN algorithm reached 91.2%, 92.5%, and 93.8%, respectively. The recall rate of the three algorithms amounted to 83.55%, 84.5%, and 86.4%, respectively. Both localization precision and recall rate of the DADRN algorithm were higher than those of other two algorithms (P < 0.05). The drug resistance rate of streptomycin, isoniazid, and rifampin of the patients aged between 40 and 59 was all higher than those of the patients in other age groups. The drug resistance rate of streptomycin, isoniazid, and rifampin of retreated patients was all higher than those of patients initially treated. The drug resistance rate of streptomycin, isoniazid, and rifampin of the patients with tuberculosis contact was all higher than those of the patients without tuberculosis contact (P < 0.05). Based on the above results, the accuracy of CT images processed by dual attention-based dilated residual classification network algorithm was higher than that processed by other two algorithms. Age, medical history, and history of exposure to tuberculosis were the influencing factors of the drug resistance of patients with pulmonary tuberculosis.


Subject(s)
Tuberculosis, Multidrug-Resistant , Tuberculosis, Pulmonary , Tuberculosis , Adult , Algorithms , Antitubercular Agents/therapeutic use , Humans , Intelligence , Isoniazid/therapeutic use , Lung , Middle Aged , Rifampin/therapeutic use , Streptomycin/therapeutic use , Tomography, X-Ray Computed , Tuberculosis/drug therapy , Tuberculosis, Multidrug-Resistant/diagnostic imaging , Tuberculosis, Multidrug-Resistant/drug therapy , Tuberculosis, Pulmonary/diagnostic imaging , Tuberculosis, Pulmonary/drug therapy
10.
Stud Health Technol Inform ; 281: 512-513, 2021 May 27.
Article in English | MEDLINE | ID: mdl-34042626

ABSTRACT

In this study, an attempt has been made to differentiate Drug Resistant Tuberculosis (DR-TB) in chest X-rays using projection profiling and mediastinal features. DR-TB is a condition which is non-responsive to at least one of anti-TB drugs. Mediastinum variations can be considered as significant image biomarkers for detection of DR-TB. Images are obtained from a public database and are contrast enhanced using coherence filtering. Projection profiling is used to obtain the feature lines from which the mediastinal and thoracic indices are computed. Classification of Drug Sensitive (DS-TB) and DR-TB is performed using three classifiers. Results show that the mediastinal features are found to be statistically significant. Support vector machine with quadratic kernel is able to provide better classification performance values of greater than 93%. Hence, the automated analysis of mediastinum could be clinically significant in differentiation of DR-TB.


Subject(s)
Tuberculosis, Multidrug-Resistant , Data Management , Databases, Factual , Humans , Support Vector Machine , Tuberculosis, Multidrug-Resistant/diagnostic imaging , Tuberculosis, Multidrug-Resistant/drug therapy , X-Rays
11.
Annu Int Conf IEEE Eng Med Biol Soc ; 2021: 2964-2967, 2021 11.
Article in English | MEDLINE | ID: mdl-34891867

ABSTRACT

Tuberculosis (TB) is a serious infectious disease that mainly affects the lungs. Drug resistance to the disease makes it more challenging to control. Early diagnosis of drug resistance can help with decision making resulting in appropriate and successful treatment. Chest X-rays (CXRs) have been pivotal to identifying tuberculosis and are widely available. In this work, we utilize CXRs to distinguish between drug-resistant and drug-sensitive tuberculosis. We incorporate Convolutional Neural Network (CNN) based models to discriminate the two types of TB, and employ standard and deep learning based data augmentation methods to improve the classification. Using labeled data from NIAID TB Portals and additional non-labeled sources, we were able to achieve an Area Under the ROC Curve (AUC) of up to 85% using a pretrained InceptionV3 network.


Subject(s)
Tuberculosis, Multidrug-Resistant , Tuberculosis , Area Under Curve , Humans , Neural Networks, Computer , Radiography , Tuberculosis, Multidrug-Resistant/diagnostic imaging , Tuberculosis, Multidrug-Resistant/drug therapy
12.
J Comput Assist Tomogr ; 34(4): 559-63, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20657225

ABSTRACT

OBJECTIVE: To describe the computed tomography (CT) findings of pulmonary extensively drug-resistant tuberculosis (XDR-TB) in non-HIV-infected patients and to compare them with those of non-XDR multidrug-resistant tuberculosis (MDR-TB). METHODS: Retrospective review of microbiological results and drug-susceptibility tests of 260 non-HIV-infected patients who had been diagnosed with pulmonary MDR-TB from 1994 to 2005 revealed that 47 patients had XDR-TB, whereas the other 213 patients had non-XDR MDR-TB. Twenty of the 47 XDR-TB patients and 85 of the 213 non-XDR MDR-TB patients with available CT examinations were included in this study. Two radiologists reviewed the CT studies in consensus for the presence and extent of micronodules, tree-in-bud appearance, lobular consolidation (<2 cm), consolidation, cavity, bronchiectasis, emphysema, pleural effusion, lymphadenopathy, bronchopleural fistula, and empyema. We then compared the CT features of XDR-TB with those of non-XDR MDR-TB. RESULTS: Micronodules and tree-in-bud appearance were the most frequent CT abnormalities and were seen in all XDR-TB patients (100%). Consolidations, cavities, bronchiectasis, and lobular consolidations were found in 85%, 85%, 80%, and 70% of XDR-TB patients, respectively. The extents of micronodules, tree-in-bud appearance, lobular consolidation, consolidation, cavity, bronchiectasis, and emphysema were 3.60, 3.55, 1.35, 1.85, 1.65, 1.45, and 0.25 lobes, respectively. Compared with non-XDR MDR-TB, XDR-TB showed a significantly larger extent of tree-in-bud appearance and consolidation (P < 0.05). With respect to other CT features, there were no significant differences between XDR-TB and non-XDR MDR-TB. CONCLUSION: Computed tomography findings of pulmonary XDR-TB are similar to those of non-XDR MDR-TB; however, XDR-TB tends to have more extensive consolidation and tree-in-bud appearance.


Subject(s)
Drug Resistance, Bacterial , Tomography, X-Ray Computed/methods , Tuberculosis, Multidrug-Resistant/diagnostic imaging , Tuberculosis, Multidrug-Resistant/drug therapy , Tuberculosis, Pulmonary/diagnostic imaging , Adolescent , Adult , Aged , Aged, 80 and over , Bronchial Diseases/complications , Bronchial Diseases/diagnostic imaging , Contrast Media , Drug Resistance, Multiple, Bacterial , Empyema, Tuberculous/complications , Empyema, Tuberculous/diagnostic imaging , Female , HIV Infections/complications , Humans , Iohexol/analogs & derivatives , Lung/diagnostic imaging , Lung/microbiology , Lymphatic Diseases/complications , Lymphatic Diseases/diagnostic imaging , Male , Middle Aged , Observer Variation , Pleural Effusion/complications , Pleural Effusion/diagnostic imaging , Pulmonary Emphysema/complications , Pulmonary Emphysema/diagnostic imaging , Radiographic Image Enhancement/methods , Retrospective Studies , Tuberculosis, Multidrug-Resistant/complications , Tuberculosis, Pulmonary/complications , Tuberculosis, Pulmonary/drug therapy , Young Adult
13.
PLoS One ; 15(10): e0239431, 2020.
Article in English | MEDLINE | ID: mdl-33017424

ABSTRACT

BACKGROUND: The loss of muscle mass in primary multidrug-resistant tuberculosis (MDR-TB) has not been examined in previous studies. This study aimed to investigate that low pectoralis muscle index and characteristic CT features can help differentiate patients with primary MDR-TB from those with drug-sensitive tuberculosis (DS-TB). MATERIAL AND METHODS: From 2010 to 2016, we retrospectively enrolled 90 patients with primary MDR-TB and 90 age- and sex-matched patients with primary DS-TB. The pectoralis muscle mass was quantitatively measured on axial CT images using density histogram analysis. The pectoralis muscle index (PMI) was defined as the pectoralis muscle mass divided by body mass index. We compared the PMI and characteristic CT features of pulmonary tuberculosis between the two groups. RESULTS: Low PMI, segmental to lobar consolidation, cavity in consolidation, cavitary nodule or mass, and bilateral involvement were more frequently observed in patients with MDR-TB than in those with DS-TB. In stepwise multivariate logistic regression analysis, low PMI (odds ratio, 2.776; 95% confidence interval, 1.450-5.314; p = 0.002), segmental or lobar consolidation (odds ratio, 3.123; 95% confidence interval, 1.629-5.987; p = 0.001), and cavitary nodule or mass (odds ratio, 2.790; 95% confidence interval, 1.348-5.176; p = 0.002) were significant factors for MDR-TB. CONCLUSION: Low pectoralis muscle index, segmental to lobar consolidation and cavitary nodule or mass can help differentiate primary MDR-TB from DS-TB.


Subject(s)
Lung/pathology , Pectoralis Muscles/pathology , Tuberculosis, Multidrug-Resistant/pathology , Antitubercular Agents/therapeutic use , Female , Humans , Image Processing, Computer-Assisted , Lung/drug effects , Male , Middle Aged , Organ Size , Pectoralis Muscles/diagnostic imaging , Retrospective Studies , Tomography, X-Ray Computed , Tuberculosis, Multidrug-Resistant/diagnostic imaging
14.
Nat Med ; 26(9): 1435-1443, 2020 09.
Article in English | MEDLINE | ID: mdl-32601338

ABSTRACT

A burgeoning epidemic of drug-resistant tuberculosis (TB) threatens to derail global control efforts. Although the mechanisms remain poorly clarified, drug-resistant strains are widely believed to be less infectious than drug-susceptible strains. Consequently, we hypothesized that lower proportions of patients with drug-resistant TB would have culturable Mycobacterium tuberculosis from respirable, cough-generated aerosols compared to patients with drug-susceptible TB, and that multiple factors, including mycobacterial genomic variation, would predict culturable cough aerosol production. We enumerated the colony forming units in aerosols (≤10 µm) from 452 patients with TB (227 with drug resistance), compared clinical characteristics, and performed mycobacterial whole-genome sequencing, dormancy phenotyping and drug-susceptibility analyses on M. tuberculosis from sputum. After considering treatment duration, we found that almost half of the patients with drug-resistant TB were cough aerosol culture-positive. Surprisingly, neither mycobacterial genomic variants, lineage, nor dormancy status predicted cough aerosol culture positivity. However, mycobacterial sputum bacillary load and clinical characteristics, including a lower symptom score and stronger cough, were strongly predictive, thereby supporting targeted transmission-limiting interventions. Effective treatment largely abrogated cough aerosol culture positivity; however, this was not always rapid. These data question current paradigms, inform public health strategies and suggest the need to redirect TB transmission-associated research efforts toward host-pathogen interactions.


Subject(s)
Aerosols/analysis , Antitubercular Agents/therapeutic use , Cough/microbiology , Tuberculosis, Multidrug-Resistant/drug therapy , Tuberculosis, Pulmonary/drug therapy , Adult , Female , Humans , Male , Middle Aged , Mycobacterium tuberculosis/drug effects , Sputum/microbiology , Tuberculosis, Multidrug-Resistant/diagnostic imaging , Tuberculosis, Multidrug-Resistant/transmission , Tuberculosis, Pulmonary/diagnostic imaging , Tuberculosis, Pulmonary/transmission
15.
J Comput Assist Tomogr ; 33(6): 956-60, 2009.
Article in English | MEDLINE | ID: mdl-19940667

ABSTRACT

OBJECTIVE: This study was designed to identify and describe thin-section computed tomographic (CT) findings of primary multidrug-resistant tuberculosis (MDR TB) as compared with the findings for drug-sensitive TB. METHODS: Between October 2002 and December 2007, thin-section chest CT findings of 39 patients with primary MDR TB and 39 patients with drug-sensitive TB were retrospectively reviewed. The frequency and patterns of lung lesions (including centrilobular nodules, large nodules, consolidation, cavity, fibrotic bands, bronchiectasis, calcification, pleural effusion, lymphadenopathy, number of lobes affected by parenchymal lesions, and laterality) were compared. Statistical comparisons were performed with the use of the chi2 and the Mann-Whitney U tests for univariate analysis, and a stepwise logistic regression method was used for multivariate analysis. RESULTS: Based on univariate analysis, bilateral involvement (P < 0.001), segmental or lobar consolidation (P < 0.001), and cavities (P < 0.001) were more frequently seen in primary MDR TB patients. A stepwise logistic regression analysis demonstrated that bilateral involvement of parenchymal lesions (odds ratio, 4.7; 95% confidence interval, 1.4-15.6; P = 0.012) and multiple cavities (odds ratio, 1.7; 95% confidence interval, 1.2-2.5; P = 0.004) were significant CT findings associated with primary MDR TB. CONCLUSIONS: The presence of primary MDR TB as detected on a CT scan may help the use of appropriate therapy for infected patients before obtaining a definite diagnosis based on bacteriology.


Subject(s)
Tomography, X-Ray Computed/methods , Tuberculosis, Multidrug-Resistant/diagnostic imaging , Adolescent , Adult , Aged , Aged, 80 and over , Blotting, Western , Chi-Square Distribution , Child , Contrast Media , Female , Humans , Logistic Models , Male , Middle Aged , Radiography, Thoracic , Retrospective Studies , Statistics, Nonparametric
16.
Thorac Cardiovasc Surg ; 57(4): 222-5, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19670116

ABSTRACT

BACKGROUND: Multidrug resistant tuberculosis (MDR-TB) still continues to be a serious health problem throughout the world. Although main treatment of MDR-TB is medical, surgical resection with adjuvant medical therapy may increase the chance of cure in selected patients. METHODS: We performed surgical resections in 55 patients between 1997 and 2005; 36 were male and 19 were female with a median age of 34 years (range 13 to 66 years). Sputum was negative for 49 patients and positive for 6 patients in the preoperative period. Patients were treated according to a new therapy protocol for a mean of 3.7 months before the operation. RESULTS: Lobectomy was performed in 37 patients, pneumonectomy in 17 patients and lobectomy + segmentectomy in 1 patient. One patient with positive sputum preoperatively died in the early postoperative period (mortality: 1.81 %). Various complications occurred in 16 (29.09 %) patients. Prolonged air leak was the most common complication (n = 8). Bronchopleural fistula (BPF) + empyema occurred in 2 (3.63 %) patients. In the postoperative period, sputum negativity was achieved in all patients except three cases throughout the 57 months of follow-up (cure rate 94.5 %). Patients received drug therapy for 24 months postoperatively. CONCLUSIONS: Surgical resection with adjuvant drug therapy increases the chance of cure in patients with localized disease if they have an adequate cardiopulmonary reserve, favorable nutritional status and are treated with a new therapy protocol for at least 3 months.


Subject(s)
Tuberculosis, Multidrug-Resistant/surgery , Tuberculosis, Pulmonary/surgery , Adolescent , Adult , Aged , Chemotherapy, Adjuvant , Female , Follow-Up Studies , Humans , Male , Middle Aged , Pneumonectomy/methods , Postoperative Complications , Sputum/microbiology , Tomography, X-Ray Computed , Treatment Outcome , Tuberculosis, Multidrug-Resistant/diagnostic imaging , Tuberculosis, Multidrug-Resistant/drug therapy , Tuberculosis, Multidrug-Resistant/mortality , Tuberculosis, Pulmonary/diagnostic imaging , Tuberculosis, Pulmonary/drug therapy , Young Adult
17.
PLoS One ; 14(5): e0217410, 2019.
Article in English | MEDLINE | ID: mdl-31120982

ABSTRACT

The NIAID TB Portals Program (TBPP) established a unique and growing database repository of socioeconomic, geographic, clinical, laboratory, radiological, and genomic data from patient cases of drug-resistant tuberculosis (DR-TB). Currently, there are 2,428 total cases from nine country sites (Azerbaijan, Belarus, Moldova, Georgia, Romania, China, India, Kazakhstan, and South Africa), 1,611 (66%) of which are multidrug- or extensively-drug resistant and 1,185 (49%), 863 (36%), and 952 (39%) of which contain X-ray, computed tomography (CT) scan, and genomic data, respectively. We introduce the Data Exploration Portal (TB DEPOT, https://depot.tbportals.niaid.nih.gov) to visualize and analyze these multi-domain data. The TB DEPOT leverages the TBPP integration of clinical, socioeconomic, genomic, and imaging data into standardized formats and enables user-driven, repeatable, and reproducible analyses. It furthers the TBPP goals to provide a web-enabled analytics platform to countries with a high burden of multidrug-resistant TB (MDR-TB) but limited IT resources and inaccessible data, and enables the reusability of data, in conformity with the NIH's Findable, Accessible, Interoperable, and Reusable (FAIR) principles. TB DEPOT provides access to "analysis-ready" data and the ability to generate and test complex clinically-oriented hypotheses instantaneously with minimal statistical background and data processing skills. TB DEPOT is also promising for enhancing medical training and furnishing well annotated, hard to find, MDR-TB patient cases. TB DEPOT, as part of TBPP, further fosters collaborative research efforts to better understand drug-resistant tuberculosis and aid in the development of novel diagnostics and personalized treatment regimens.


Subject(s)
Databases, Factual , Tuberculosis, Multidrug-Resistant , Big Data , Cohort Studies , Data Analysis , Drug Resistance, Multiple, Bacterial/genetics , Genome, Bacterial , Humans , Mycobacterium tuberculosis/drug effects , Mycobacterium tuberculosis/genetics , National Institute of Allergy and Infectious Diseases (U.S.) , Polymorphism, Single Nucleotide , Tuberculosis, Multidrug-Resistant/diagnostic imaging , Tuberculosis, Multidrug-Resistant/drug therapy , Tuberculosis, Multidrug-Resistant/microbiology , United States , Web Browser
18.
PLoS One ; 14(8): e0220946, 2019.
Article in English | MEDLINE | ID: mdl-31415616

ABSTRACT

Drug-resistant tuberculosis (DR-TB) remains a major global health problem. Early treatment of TB is critical; in the absence of rapid- susceptibility testing, the empiric selection of drugs should be guided by clinical data. This study aimed to determine the clinical predictors of DR-TB. From September 2010 to August 2017, sociodemographic and clinical characteristics were collected from 144 patients with tuberculosis at the Hospital Civil de Guadalajara, Mexico. Isolates were subjected to drug-susceptibility testing. Clinical predictors of DR-TB were determined using univariate and multivariate analysis. Any drug, isoniazid, and rifampin resistance rates were 47.7, 23.0, and 11.6%, respectively. The visualization of cavities and nodules through either chest radiography or computed tomography were independent predictors of DR-TB. In conclusion, early detection of DR-TB in this population could be based on multiple cavities being observed using chest imaging. This study's results can be applied to future patients with TB in our community to optimize the DR-TB diagnostic process.


Subject(s)
Mycobacterium tuberculosis , Tuberculosis, Multidrug-Resistant , Tuberculosis, Pulmonary , Adult , Antitubercular Agents/pharmacology , Female , Humans , Isoniazid/pharmacology , Male , Mexico , Middle Aged , Rifampin/pharmacology , Tuberculosis, Multidrug-Resistant/diagnostic imaging , Tuberculosis, Multidrug-Resistant/drug therapy , Tuberculosis, Multidrug-Resistant/epidemiology , Tuberculosis, Pulmonary/diagnostic imaging , Tuberculosis, Pulmonary/drug therapy , Tuberculosis, Pulmonary/epidemiology
19.
Acta Medica (Hradec Kralove) ; 62(1): 24-29, 2019.
Article in English | MEDLINE | ID: mdl-30931893

ABSTRACT

BACKGROUND: Tuberculosis (TB) remains a burden globally, including Indonesia. The primary objective of this study is to reveal the chest radiography characteristic of drug-sensitive TB (DS-TB) and multi-drug resistant TB (MDR-TB) in the Indonesian national tuberculosis prevalence survey 2013-2014. The secondary objective is to explore the correlation and incidence rate of chest radiography lesion of DS-TB and MDR-TB cases. METHODS: This is a cross-sectional retrospective analytical studies with national and regional coverage. Samples were selected by stratified multi-stage clustering sampling technique in a population aged ≥15 years old. The diagnosis of TB was based on culture and GeneXpert tests. RESULTS: There were 147 DS-TB and 11 MDR-TB patients that were analyzed in this study. The nodule is the only type of lesions that distinguish MDR-TB and DS-TB. In multivariate analysis of DS-TB, there were 3 significant chest radiography lesions, i.e infiltrate, cavity and consolidation with odd-ratio (OR) of 14, 13, and 3, respectively. In MDR-TB, the only significant lesion is a nodule, with OR of 19. CONCLUSION: Nodule is the only type of lesions that distinguish MDR-TB and DS-TB. Infiltrate, cavity and consolidation were the types of chest radiography lesions on DS-TB, meanwhile, a nodule was the only significant lesion for MDR-TB.


Subject(s)
Drug Resistance, Bacterial/drug effects , Health Surveys , Lung/diagnostic imaging , Radiography, Thoracic , Tuberculosis, Multidrug-Resistant/diagnostic imaging , Tuberculosis, Multidrug-Resistant/microbiology , Adolescent , Adult , Cross-Sectional Studies , Female , Humans , Image Processing, Computer-Assisted , Indonesia/epidemiology , Lung/pathology , Male , Middle Aged , Prevalence , Retrospective Studies , Tuberculosis, Multidrug-Resistant/epidemiology , Tuberculosis, Multidrug-Resistant/pathology , Young Adult
20.
Indian J Tuberc ; 66(1): 49-57, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30797283

ABSTRACT

OBJECTIVES: Central nervous system (CNS) is an important site for extrapulmonary tuberculosis. The present study evaluated the spectrum of CNS tuberculosis in a high tuberculosis endemic region. METHODS: The study included 306 cases of CNS tuberculosis. All cases were assessed for clinical evaluation and neuroimaging. All cases were followed up for 3 months. Modified Barthel index was used to assess the outcome. RESULTS: Out of 306 cases of CNS tuberculosis, 174 (56.86%) had intracranial tuberculosis, 55 (17.97%) had spinal tuberculosis, 15 (4.91%) had both intracranial and spinal pathology. Sixty-two (20.26%) patients had disseminated tuberculosis. Two-hundred and fourteen (69.9%) cases had tuberculous meningitis. Disseminated tuberculosis patients had significantly poor modified Barthel index and 3-month outcome. Culture positivity was significantly higher in the disseminated group. Ten (27.02%) out of 37 culture positive tuberculous meningitis cases had multi-drug-resistant tuberculosis. On multivariate analysis disseminated tuberculosis, baseline modified Barthel index ≤12, and stage 3 predicted poor outcome. Fifty-five patients had spinal tuberculosis. Thirty-four (75.56%) patients with Pott's spine improved with antituberculosis treatment and only 11 (24.44%) patients had modified Barthel index ≤12, after 3 months. CONCLUSIONS: In tuberculosis-endemic areas a varied form of CNS tuberculosis is frequent. CNS tuberculosis is often part of disseminated tuberculosis.


Subject(s)
Antitubercular Agents/therapeutic use , Myelitis/epidemiology , Tuberculoma, Intracranial/epidemiology , Tuberculosis, Meningeal/epidemiology , Tuberculosis, Multidrug-Resistant/epidemiology , Adolescent , Adult , Drug Therapy, Combination , Duration of Therapy , Female , Glucocorticoids/therapeutic use , Humans , India/epidemiology , Magnetic Resonance Imaging , Male , Middle Aged , Myelitis/diagnostic imaging , Myelitis/drug therapy , Tertiary Care Centers , Tomography, X-Ray Computed , Tuberculoma, Intracranial/diagnostic imaging , Tuberculoma, Intracranial/drug therapy , Tuberculosis, Central Nervous System/diagnostic imaging , Tuberculosis, Central Nervous System/drug therapy , Tuberculosis, Central Nervous System/epidemiology , Tuberculosis, Meningeal/diagnostic imaging , Tuberculosis, Meningeal/drug therapy , Tuberculosis, Multidrug-Resistant/diagnostic imaging , Tuberculosis, Multidrug-Resistant/drug therapy , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL